Influence of tumour laterality on patient survival in non-small cell lung cancer after radiotherapy
AffiliationDivision Clinical Cancer Science, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, UK
MetadataShow full item record
AbstractBACKGROUND: Lung cancer survival after radiotherapy remains poor and greater knowledge of normal tissue risk factors is needed to further optimise treatments. In this work, we investigate tumour laterality in a large cohort of patients treated with curative-intent radiotherapy, including the effect of dose on the right and left lungs. METHODS: 1101 NSCLC patients were included in the analysis, treated with 55?Gy in 20 fractions. Tumour laterality was determined by comparing the centre of mass of the tumour volume with the centre of mass of the lung. Right and left lungs were segmented from the whole lung contour and the mean dose to each volume calculated. Laterality and mean lung doses were included in multi-variable cox-regression survival models. RESULTS: 1026 patients were eligible for inclusion; 579 right-sided and 447 left-sided tumours were identified. All tumour and patient characteristics were balanced with laterality. The multi-variable models were controlled for known clinical factors: tumour volume (p?<?0.001), age (p?<?0.001), performance status (p?<?0.05) and nodal stage (p?<?0.01). Multi-variable analysis showed laterality to be highly significant (p?<?0.01) with right-sided tumours showing worse overall survival than left-sided tumours (15 versus 18?months). The right lung mean dose was found to be significant (p?=?0.03) for overall survival but the left lung mean dose was not (p?=?0.78). CONCLUSION: Our study showed that right-sided lung tumours show worse overall survival for NSCLC treated with curative-intent radiotherapy. Results suggest that the effect of laterality is through a difference in dose-response for individual lungs, with the larger, right lung, having the greater impact on survival.
CitationMcWilliam A, Vasquez Osorio E, Faivre-Finn C, van Herk M. Influence of tumour laterality on patient survival in non-small cell lung cancer after radiotherapy. Radiother Oncol. 2019;137:71-6.
JournalRadiotherapy and Oncology
- The effect of tumor laterality on survival for non-small cell lung cancer patients treated with radiotherapy.
- Authors: Jørgensen N, Meline EL, Jeppesen SS, Hansen O, Nielsen M, Schytte T
- Issue date: 2019 Jul 4
- Prognostic and predictive value of primary tumour side in patients with RAS wild-type metastatic colorectal cancer treated with chemotherapy and EGFR directed antibodies in six randomized trials.
- Authors: Arnold D, Lueza B, Douillard JY, Peeters M, Lenz HJ, Venook A, Heinemann V, Van Cutsem E, Pignon JP, Tabernero J, Cervantes A, Ciardiello F
- Issue date: 2017 Aug 1
- Immunotherapy (excluding checkpoint inhibitors) for stage I to III non-small cell lung cancer treated with surgery or radiotherapy with curative intent.
- Authors: Zhu J, Li R, Tiselius E, Roudi R, Teghararian O, Suo C, Song H
- Issue date: 2017 Dec 16
- Palliative radiotherapy regimens for patients with thoracic symptoms from non-small cell lung cancer.
- Authors: Stevens R, Macbeth F, Toy E, Coles B, Lester JF
- Issue date: 2015 Jan 14
- Long-term mortality from heart disease and lung cancer after radiotherapy for early breast cancer: prospective cohort study of about 300,000 women in US SEER cancer registries.
- Authors: Darby SC, McGale P, Taylor CW, Peto R
- Issue date: 2005 Aug